Evidence for transcriptional regulation of the glucose-6-phosphate transporter by HIF-1alpha: Targeting G6PT with mumbaistatin analogs in hypoxic mesenchymal stromal cells
- PMID: 19074414
- PMCID: PMC2728688
- DOI: 10.1634/stemcells.2008-0855
Evidence for transcriptional regulation of the glucose-6-phosphate transporter by HIF-1alpha: Targeting G6PT with mumbaistatin analogs in hypoxic mesenchymal stromal cells
Abstract
Mesenchymal stromal cell (MSC) markers are expressed on brain tumor-initiating cells involved in the development of hypoxic glioblastoma. Given that MSCs can survive hypoxia and that the glucose-6-phosphate transporter (G6PT) provides metabolic control that contributes to MSC mobilization and survival, we investigated the effects of low oxygen (1.2% O(2)) exposure on G6PT gene expression. We found that MSCs significantly expressed G6PT and the glucose-6-phosphatase catalytic subunit beta, whereas expression of the glucose-6-phosphatase catalytic subunit alpha and the islet-specific glucose-6-phosphatase catalytic subunit-related protein was low to undetectable. Analysis of the G6PT promoter sequence revealed potential binding sites for hypoxia inducible factor (HIF)-1alpha and for the aryl hydrocarbon receptor (AhR) and its dimerization partner, the AhR nuclear translocator (ARNT), AhR:ARNT. In agreement with this, hypoxia and the hypoxia mimetic cobalt chloride induced the expression of G6PT, vascular endothelial growth factor (VEGF), and HIF-1alpha. Gene silencing of HIF-1alpha prevented G6PT and VEGF induction in hypoxic MSCs whereas generation of cells stably expressing HIF-1alpha resulted in increased endogenous G6PT gene expression. A semisynthetic analog of the polyketide mumbaistatin, a potent G6PT inhibitor, specifically reduced MSC-HIF-1alpha cell survival. Collectively, our data suggest that G6PT may account for the metabolic flexibility that enables MSCs to survive under conditions characterized by hypoxia and could be specifically targeted within developing tumors.
Figures
Similar articles
-
A concerted HIF-1α/MT1-MMP signalling axis regulates the expression of the 3BP2 adaptor protein in hypoxic mesenchymal stromal cells.PLoS One. 2011;6(6):e21511. doi: 10.1371/journal.pone.0021511. Epub 2011 Jun 27. PLoS One. 2011. PMID: 21738685 Free PMC article.
-
LincRNA-p21 promotes mesenchymal stem cell migration capacity and survival through hypoxic preconditioning.Stem Cell Res Ther. 2018 Oct 25;9(1):280. doi: 10.1186/s13287-018-1031-x. Stem Cell Res Ther. 2018. PMID: 30359325 Free PMC article.
-
NcoA2-Dependent Inhibition of HIF-1α Activation Is Regulated via AhR.Toxicol Sci. 2015 Dec;148(2):517-30. doi: 10.1093/toxsci/kfv199. Epub 2015 Sep 8. Toxicol Sci. 2015. PMID: 26350169
-
Regulatory crosstalk and interference between the xenobiotic and hypoxia sensing pathways at the AhR-ARNT-HIF1α signaling node.Chem Biol Interact. 2014 Jul 25;218:82-8. doi: 10.1016/j.cbi.2014.05.001. Epub 2014 May 10. Chem Biol Interact. 2014. PMID: 24824450 Free PMC article. Review.
-
A review on transcriptional regulation responses to hypoxia in mesenchymal stem cells.Cell Biol Int. 2020 Jan;44(1):14-26. doi: 10.1002/cbin.11211. Epub 2019 Aug 28. Cell Biol Int. 2020. PMID: 31393053 Review.
Cited by
-
A concerted HIF-1α/MT1-MMP signalling axis regulates the expression of the 3BP2 adaptor protein in hypoxic mesenchymal stromal cells.PLoS One. 2011;6(6):e21511. doi: 10.1371/journal.pone.0021511. Epub 2011 Jun 27. PLoS One. 2011. PMID: 21738685 Free PMC article.
-
Erythropoietin-mediated expression of placenta growth factor is regulated via activation of hypoxia-inducible factor-1α and post-transcriptionally by miR-214 in sickle cell disease.Biochem J. 2015 Jun 15;468(3):409-23. doi: 10.1042/BJ20141138. Epub 2015 Apr 16. Biochem J. 2015. PMID: 25876995 Free PMC article.
-
Priming of the Cells: Hypoxic Preconditioning for Stem Cell Therapy.Chin Med J (Engl). 2017 Oct 5;130(19):2361-2374. doi: 10.4103/0366-6999.215324. Chin Med J (Engl). 2017. PMID: 28937044 Free PMC article. Review.
-
In vitro biomaterial priming of human mesenchymal stromal/stem cells : implication of the Src/JAK/STAT3 pathway in vasculogenic mimicry.Sci Rep. 2024 Sep 13;14(1):21444. doi: 10.1038/s41598-024-72862-6. Sci Rep. 2024. PMID: 39271790 Free PMC article.
-
Hypoxic conditioned medium from human amniotic fluid-derived mesenchymal stem cells accelerates skin wound healing through TGF-β/SMAD2 and PI3K/Akt pathways.Int J Mol Sci. 2014 Jan 6;15(1):605-28. doi: 10.3390/ijms15010605. Int J Mol Sci. 2014. PMID: 24398984 Free PMC article.
References
-
- Tso CL, Shintaku P, Chen J, et al. Primary glioblastomas express mesenchymal stem-like properties. Mol Cancer Res. 2006;4:607–619. - PubMed
-
- Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997;276:71–74. - PubMed
-
- Horwitz EM, Le Blanc K, Dominici M, et al. The International Society for Cellular Therapy. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy. 2005;7:393–395. - PubMed
-
- Studeny M, Marini FC, Champlin RE, et al. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res. 2002;62:3603–3608. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
